X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Myasthenia Gravis Therapeutics Companies

This report lists the top Myasthenia Gravis Therapeutics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Myasthenia Gravis Therapeutics industry.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Immune System Drugs Research Autoimmune Disorders Research Myasthenia Gravis Therapeutics Market Companies

Myasthenia Gravis Therapeutics Top Companies

  1. Alexion Pharmaceuticals Inc

  2. Mitsubishi Tanabe Pharma

  3. Astellas Pharma

  4. Bausch Health

  5. UCB S.A.

*Disclaimer: Top companies sorted in no particular order

Myasthenia Gravis Therapeutics Market Major Players

Myasthenia Gravis Therapeutics Market Concentration

Myasthenia Gravis Therapeutics Market Concentration

Myasthenia Gravis Therapeutics Company List

                            • Alexion Pharmaceutical Inc.

                            • Argenx

                            • Astellas Pharma

                            • CuraVac

                            • Grifols SA

                            • Immunovant

                            • Mitsubishi Tanabe Pharma

                            • Novartis

                            • UCB Pharma

                            • Bausch Health


                        Specific to Myasthenia Gravis Therapeutics Market
                        Need More Details On Market Players And Competitors?
                        Download Sample

                        Myasthenia Gravis Therapeutics Report Snapshots

                        Myasthenia Gravis Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)